LPSN

LivePerson is a melting ice cube dressed up by cost cuts. Revenue has collapsed from $470M in FY2021 to $244M in FY2025 — down 22% again in the latest year — and there is nothing in the numbers or the MD&A to suggest the decline has bottomed. The narrowing net loss (-$67.2M vs. -$134M) is not a growth story; it is the arithmetic of retrenchment. Management slashed sales & marketing 22%, G&A 44%, and product development 31%, gutting headcount across every function (S&M headcount 224→129, product dev 405→239). The MD&A itself concedes the company is 'operating in a competitive environment characterized by aggressive investment in artificial intelligence… by competitors with significant resources' — and LivePerson's response is to cut R&D 31% to $54.7M. Starving product development while better-capitalized rivals pour money into AI is a recipe for continued revenue erosion, not stabilization.

The balance sheet is the disqualifier. Stockholders' equity is negative (-$44.5M), retained-earnings deficit is -$1.06B, and the FY2023 debt figures still on record show $512M long-term plus $72.4M current — a debt load more than 20x the entire $23.3M equity market cap. Cash fell 48% in a year to $95M while operating cash flow ran -$30.4M. So the company is burning cash, carries far more debt than its equity is worth, and has a shrinking asset base (total assets -25%). This is the profile of a distressed capital structure where the equity is a thin residual claim behind the debt — effectively an out-of-the-money option on a successful restructuring or refinancing, not an ownership stake in a going concern.